Olaris® combines metabolomics, machine learning and biology to revolutionize how diseases are diagnosed and treated. With an initial focus on transplant, we are developing diagnostics to transform the transplant journey. 

​

myOLARIS™ - KTdx measures urinary metabolites combined with BKV PCR and serum creatinine values to calculate a score that correlates with the likelihood a transplant patient has a stable graft or a graft injury that could be caused by inadequate immunosuppression including under-immunosuppression experiencing borderline or active rejection or over-immunosuppressed, experiencing polyomavirus associated nephropathy (PVAN)​​.  

​

The findings are applicable to men and women who have received a kidney transplant and are receiving the immunosuppressant tacrolimus and mycophenolate.  

​

Urine is collected in the myOLARIS™ - KTdx collection kit either in a physician office or at home, sent back to our CLIA lab in Framingham MA and a report will be sent back to you including a myOLARIS™ - KTdx score.   The score uses a proprietary algorithm to identify the likelihood a patient has a stable graft or graft injury by comparing the patient’s urinary metabolite levels and clinical labs to those of previous patients with defined clinical phenotypes based on matched biopsy results. The score ranges from 0 to 100% Stable or 0 to 100% Injury with higher scores having more confidence in the diagnosis.  

 

DISCLAIMER

The results provided by this diagnostic kit are intended for informational purposes only and should not be used as a basis for self-diagnosis or treatment.

​

It is essential to consult your primary care physician or medical care team before taking any action based on these results.

 

Only a licensed healthcare provider can interpret your results in the context of your overall health and provide appropriate medical advice and treatment.

 

If you would like to order our diagnostic test kit, please provide the information below and we will follow-up with you.